ImprimisRx NJ 2022-11-23 Health serious FDA
Health · FDA · Recall #FDA-D-0060-2023
Timolol-Latanoprost (0.5/0.005%) ophthalmic drops, Compounded, 5 mL bottle, Imprimis Rx,… Recall
Issued November 23, 2022 · ImprimisRx NJ
In November 2022, ImprimisRx NJ recalled the Timolol-Latanoprost (0.5/0.005%) ophthalmic drops, Compounded, 5 mL bottle, Imprimis Rx,…, a serious health recall reported by the FDA.
Compiled by Maya Ellison, RecallCheckr
What this means for you
Subpotent Drug: The batches contain less than 90% of the labeled amount of latanoprost.
What you should do
- 1 Stop using Timolol-Latanoprost (0.5/0.005%) ophthalmic drops, Compounded, 5 mL bottle, Imprimis Rx,… right away.
- 2 Set it aside where it won't be used by mistake.
- 3 Contact ImprimisRx NJ to arrange your voluntary. See the official notice below for contact details.
- 4 Keep the product until your remedy is fully processed. You may need it.
Official remedy (Voluntary):
Recall details
- Brand
- ImprimisRx NJ
- Category
- Health
- Recall date
- November 23, 2022
- Units affected
- Not reported
- Sold at
- Nationwide in the USA
- Recall number
- FDA-D-0060-2023
- Made in
- United States
- Issuing agency
- FDA
In context
- ImprimisRx NJ has 1 recall in our database.
- We're tracking 3,576 Health recalls in our database.
- This is the 870th Health recall we've logged in 2022.